Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer

The treatment of multi-drug resistant (MDR) cancer is a clinical challenge. Many MDR cells over-express epidermal growth factor receptor (EGFR). We exploit this expression through the development of EGFR-targeted, polymer blend nanocarriers for the treatment of MDR cancer using paclitaxel (a common...

Descripción completa

Detalles Bibliográficos
Autores principales: Milane, Lara, Duan, Zhenfeng, Amiji, Mansoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169576/
https://www.ncbi.nlm.nih.gov/pubmed/21931642
http://dx.doi.org/10.1371/journal.pone.0024075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169576/
https://www.ncbi.nlm.nih.gov/pubmed/21931642
http://dx.doi.org/10.1371/journal.pone.0024075

Ejemplares similares